François-Xavier Rouxel

Gardyn (Washington)

Chief Executive Officer

François-Xavier Rouxel is Chief Executive Officer at Gardyn. He was Head of Financial Services, specifically for infrastructure at Capgemini in their Washington DC office.

Contacter

Articles

1873 Bulletin

François-Xavier Rouxel, Giuseppe Conte, Guillaume Loriot, Walter Tretton The EU Commission prohibits a merger between gas and electricity national incumbents (EDP / ENI / GDP)

9 décembre 2004 688

"EDP/ENI/GDP : the Commission prohibits a merger between gas and electricity national incumbents"* On 9 December 2004, the European Commission decided to block the proposed acquisition of Gás de Portugal (GDP), the incumbent gas company in Portugal, by both Energias de Portugal (EDP), the (...)

François-Xavier Rouxel, Guillaume Loriot, Henri Piffaut The EU Commission conditionally clears a merger in the industrial gases industry (Air Liquide / Messer)

15 mars 2004 437

"Air Liquide / Messer : addressing the changes brought about by the concentration in the industrial gases industry"* On 15 March 2004, the European Commission approved, subject to conditions, the acquisition by L’Air Liquide SA (‘Air Liquide’) of Messer Griesheim KGaA’s (‘Messer Group’) activities (...)

François-Xavier Rouxel, Geraldine Emberger, Oliver Koch The European Commission welcomes German manufacturer of bearings to withdraw its acquisition of French bearings maker (SNFA/INA/AIG)

21 janvier 2004 251

"Merger control : Main developments 1 January to 30 April 2004 INA/AIG/SNFA"* The proposed acquisition of the French precision bearing manufacturer SNFA by Europe’s leading bearing producer INA, jointly with the insurance group AIG, is an illustrative example for the impact of competition (...)

Benoît Durand, François-Xavier Rouxel, Guillaume Loriot The EU Commission approves, subject to remedies, a merger in the medical devices market giving a practical example of the use of quantitative analyses in merger control (GE Medical Systems / Instrumentarium)

2 septembre 2003 497

"GE/Instrumentarium : a practical example of the use of quantitative analyses in merger control"* On 2 September 2003, the European Commission approved, subject to conditions, the acquisition by General Electric Medical Systems (‘GE’) of the Finnish firm Instrumentarium. The Commission was (...)